The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer-Reference-Cited by-同舟云学术

The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer

Published:2016-03-31 Issue:1 Volume:9 Page:
ISSN:1757-2215
Container-title:Journal of Ovarian Research
language:en
Short-container-title:J Ovarian Res

Author:

Tamir Ayala,Gangadharan Anju,Balwani Sakshi,Tanaka Takemi,Patel Ushma,Hassan Ahmed,Benke Stephanie,Agas Agnieszka,D’Agostino Joseph,Shin Dayoung,Yoon Sunghoon,Goy Andre,Pecora Andrew,Suh K. Stephen

Funder

State of New Jersey Department of Health and Senior Services (US)

John Theurer Cancer Center of the Hackensack University Medical Center

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13048-016-0228-9

Reference42 articles.

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66.

2. Wang K, Li Y, Jiang YZ, Dai CF, Patankar MS, Song JS, Zheng J. An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells. Cancer Lett. 2013;340(1):63–71. doi: 10.1016/j.canlet.2013.06.026 .

3. Li Y, Wang K, Jiang YZ, Chang XW, Dai CF, Zheng J. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits human ovarian cancer cell proliferation. Cell Oncol (Dordr). 2014;37(6):429–37. doi: 10.1007/s13402-014-0206-4 .

4. Karam AK, Karlan BY. Ovarian cancer: the duplicity of CA125 measurement. Nat Rev Clin Oncol. 2010;7(6):335–9. doi: 10.1038/nrclinonc.2010.44 .

5. Donach M, Yu Y, Artioli G, Banna G, Feng W, Bast Jr RC, et al. Combined use of biomarkers for detection of ovarian cancer in high-risk women. Tumour Biol. 2010;31(3):209–15. doi: 10.1007/s13277-010-0032-x .

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of urine biomarkers of endometriosis—Protein mass spectrometry;American Journal of Reproductive Immunology;2024-05

2. A comparison study of canonical methods: Application to -Omics data;Korean Journal of Applied Statistics;2024-04-30

3. Biomarkers in Ovarian Cancer: Towards Personalized Medicine;Proteomes;2024-03-18

4. Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value;Journal of Ovarian Research;2024-03-16

5. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment;Frontiers in Drug Delivery;2024-02-01